Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183118 · ClinicalTrials.gov registry record · Phase 1
Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)
A Phase 1 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 180
- Enrollment target
NCT00183118: Completed Phase 1 study, sponsored by Boston Medical Center.
NCT00183118 is a Phase 1 study that has completed, run by Boston Medical Center. The registered enrollment target is 180 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (200% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00183118, a Phase 1 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 180 participants
- Enrollment target
Study Summary
The purpose of this study is to test an HIV prevention intervention in a Russian substance abuse treatment facility using a randomized trial study design.
Interventions
- BEHAVIORAL Adapted Enhanced-RESPECT (HIV prevention intervention)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-12 |
| Phase | Phase 1 |
What the finished NCT00183118 record still lists
NCT00183118 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (200% higher).
The record links to 0 conditions, and to 1 intervention - of which Adapted Enhanced-RESPECT (HIV prevention intervention) is the first listed.
NCT00183118 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00183118 about?
NCT00183118 is a clinical study titled "Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)". The purpose of this study is to test an HIV prevention intervention in a Russian substance abuse treatment facility using a randomized trial study design.
What is the current status of trial NCT00183118?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 180 participants. The study started on 2004-10. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00183118?
The interventions under investigation include: Adapted Enhanced-RESPECT (HIV prevention intervention) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00183118?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00183118's enrollment target sits among peer trials
180 299th of 2000 higher than 1,690 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia